Effectiveness and Safety of Antidepressants for Children and Adolescents: Implications for Clinical Practice

Affiliations

¹ The Werry Centre for Infant, Child and Adolescent Mental Health, Department of Psychological Medicine, University of Auckland, Auckland, New Zealand.
² Orygen, The National Centre of Excellence in Youth Mental Health and the Centre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia.

Comment

Sally Nicola Merry et al. JAMA Psychiatry. 2017.

. 2017 Oct 1;74(10):985-986.

doi: 10.1001/jamapsychiatry.2017.2410.

¹ The Werry Centre for Infant, Child and Adolescent Mental Health, Department of Psychological Medicine, University of Auckland, Auckland, New Zealand.
² Orygen, The National Centre of Excellence in Youth Mental Health and the Centre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia.

No abstract available

Comment on

Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J. Locher C, et al. JAMA Psychiatry. 2017 Oct 1;74(10):1011-1020. doi: 10.1001/jamapsychiatry.2017.2432. JAMA Psychiatry. 2017. PMID: 28854296 Free PMC article.